BTMD | biote Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.21 - 3.50
52 Week Range	3.04 - 8.44
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	336,066
Average Volume	195,322
Shares Outstanding	54,710,253
Market Cap	182,185,142
Sector
Industry
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	37.00
Forward P/E Ratio	N/A
EPS	0.09
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	0
Country
Website	BTMD

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

*Chart delayed

Analyzing fundamentals for BTMD we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is poor, Growth is desperately bad and Health is weak. For more detailed analysis please see BTMD Fundamentals page.

Watching at BTMD technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on BTMD Technicals page.